Skip to content

Clinical trials

Phase 2 Nephritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nephritis Phase: Phase 2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20151
20181
20191
20202
20211
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Completed2
Recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Goldfinch Bio, Inc.2
AstraZeneca1
Genzyme, a Sanofi Company1
Jade Biosciences, Inc.1
La Jolla Pharmaceutical Company1
Mayo Clinic1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Vera Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nephritis9
Kidney Diseases7
Glomerulonephritis5
Autoimmune Diseases3
Glomerulonephritis, IGA3
Immune System Diseases3
Lupus Nephritis2
Nephrosis2
Proteinuria2
Urologic Diseases2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.